APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Supportive Care Medicine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Supportive Care Medicine Industry Growth and Trends Forecast to 2032

20 December 2025107 pages

Choose your research edition.

Industry ResearchCancer Supportive Care Medicine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Supportive Care Medicine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Cancer Supportive Care Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Supportive Care Medicine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Supportive Care Medicine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cancer Supportive Care Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Supportive Care Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Supportive Care Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Supportive Care Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Supportive Care Medicine include Teva Pharmaceutical Industries, Johnson &Johnson, Novartis, Merck, GlaxoSmithKline, Amgen, TESARO, Kyowa Hakko Kirin and Heron Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Supportive Care Medicine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Supportive Care Medicine market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Supportive Care Medicine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Supportive Care Medicine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cancer Supportive Care Medicine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Supportive Care Medicine Market by Company

Teva Pharmaceutical Industries

Johnson &Johnson

Novartis

Merck

GlaxoSmithKline

Amgen

TESARO

Kyowa Hakko Kirin

Heron Therapeutics

Helsinn Healthcare

F. Hoffmann-La Roche

Cancer Supportive Care Medicine Segment by Type

Antiemetic Drugs

Analgesics

Granulocyte-Stimulating Agents

Erythropoietin-Stimulating Agents

Others

Cancer Supportive Care Medicine Segment by Application

Chemotherapy-Induced Anemia

Bone Metastasis

Cancer Pain

Other

Cancer Supportive Care Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Supportive Care Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Supportive Care Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Supportive Care Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Supportive Care Medicine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cancer Supportive Care Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antiemetic Drugs Table 2. Major Company of Analgesics Table 3. Major Company of Granulocyte-Stimulating Agents Table 4. Major Company of Erythropoietin-Stimulating Agents Table 5. Major Company of Others Table 6. Global Cancer Supportive Care Medicine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Cancer Supportive Care Medicine Sales by Type (2021-2026) & (k tons) Table 8. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Type (2021-2026) Table 9. Global Cancer Supportive Care Medicine Sales by Type (2021-2026) & (US$ Million) Table 10. Global Cancer Supportive Care Medicine Sales Market Share in Value by Type (2021-2026) Table 11. Global Cancer Supportive Care Medicine Price by Type (2021-2026) & (US$/ton) Table 12. Global Cancer Supportive Care Medicine Sales by Type (2027-2032) & (k tons) Table 13. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Type (2027-2032) Table 14. Global Cancer Supportive Care Medicine Sales by Type (2027-2032) & (US$ Million) Table 15. Global Cancer Supportive Care Medicine Sales Market Share in Value by Type (2027-2032) Table 16. Global Cancer Supportive Care Medicine Price by Type (2027-2032) & (US$/ton) Table 17. North America Cancer Supportive Care Medicine Sales by Type (2021-2026) & (k tons) Table 18. North America Cancer Supportive Care Medicine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Cancer Supportive Care Medicine Sales by Type (2021-2026) & (k tons) Table 20. Europe Cancer Supportive Care Medicine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Cancer Supportive Care Medicine Sales by Type (2021-2026) & (k tons) Table 22. Asia-Pacific Cancer Supportive Care Medicine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Cancer Supportive Care Medicine Sales by Type (2021-2026) & (k tons) Table 24. Latin America Cancer Supportive Care Medicine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Cancer Supportive Care Medicine Sales by Type (2021-2026) & (k tons) Table 26. Middle East and Africa Cancer Supportive Care Medicine Sales by Type (2021-2026) & (US$ Million) Table 27. Cancer Supportive Care Medicine Industry Trends Table 28. Cancer Supportive Care Medicine Industry Drivers Table 29. Cancer Supportive Care Medicine Industry Opportunities and Challenges Table 30. Cancer Supportive Care Medicine Industry Restraints Table 31. Global Cancer Supportive Care Medicine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Cancer Supportive Care Medicine Revenue Market Share by Company (2021-2026) Table 33. Global Cancer Supportive Care Medicine Sales by Company (2021-2026) & (k tons) Table 34. Global Cancer Supportive Care Medicine Sales Share by Company (2021-2026) Table 35. Global Cancer Supportive Care Medicine Market Price by Company (2021-2026) & (US$/ton) Table 36. Global Cancer Supportive Care Medicine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Cancer Supportive Care Medicine Major Company Production Sites and Headquarters Table 38. Global Cancer Supportive Care Medicine Company, Product Type & Application Table 39. Global Cancer Supportive Care Medicine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Cancer Supportive Care Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Cancer Supportive Care Medicine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Cancer Supportive Care Medicine Sales by Region (2021-2026) & (k tons) Table 44. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Region (2021-2026) Table 45. Global Cancer Supportive Care Medicine Sales by Region (2021-2026) & (US$ Million) Table 46. Global Cancer Supportive Care Medicine Sales Market Share in Value by Region (2021-2026) Table 47. Global Cancer Supportive Care Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 48. Global Cancer Supportive Care Medicine Sales by Region (2027-2032) & (k tons) Table 49. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Region (2027-2032) Table 50. Global Cancer Supportive Care Medicine Sales by Region (2027-2032) & (US$ Million) Table 51. Global Cancer Supportive Care Medicine Sales Market Share in Value by Region (2027-2032) Table 52. Global Cancer Supportive Care Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 53. Global Cancer Supportive Care Medicine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Cancer Supportive Care Medicine Sales by Application (2021-2026) & (k tons) Table 55. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Application (2021-2026) Table 56. Global Cancer Supportive Care Medicine Sales by Application (2021-2026) & (US$ Million) Table 57. Global Cancer Supportive Care Medicine Sales Market Share in Value by Application (2021-2026) Table 58. Global Cancer Supportive Care Medicine Price by Application (2021-2026) & (US$/ton) Table 59. Global Cancer Supportive Care Medicine Sales by Application (2027-2032) & (k tons) Table 60. Global Cancer Supportive Care Medicine Sales Market Share in Volume by Application (2027-2032) Table 61. Global Cancer Supportive Care Medicine Sales by Application (2027-2032) & (US$ Million) Table 62. Global Cancer Supportive Care Medicine Sales Market Share in Value by Application (2027-2032) Table 63. Global Cancer Supportive Care Medicine Price by Application (2027-2032) & (US$/ton) Table 64. North America Cancer Supportive Care Medicine Sales by Application (2021-2026) & (k tons) Table 65. North America Cancer Supportive Care Medicine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Cancer Supportive Care Medicine Sales by Application (2021-2026) & (k tons) Table 67. Europe Cancer Supportive Care Medicine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Cancer Supportive Care Medicine Sales by Application (2021-2026) & (k tons) Table 69. Asia-Pacific Cancer Supportive Care Medicine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Cancer Supportive Care Medicine Sales by Application (2021-2026) & (k tons) Table 71. Latin America Cancer Supportive Care Medicine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Cancer Supportive Care Medicine Sales by Application (2021-2026) & (k tons) Table 73. Middle East and Africa Cancer Supportive Care Medicine Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Pharmaceutical Industries Company Information Table 75. Teva Pharmaceutical Industries Business Overview Table 76. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Industries Cancer Supportive Care Medicine Product Portfolio Table 78. Teva Pharmaceutical Industries Recent Development Table 79. Johnson &Johnson Company Information Table 80. Johnson &Johnson Business Overview Table 81. Johnson &Johnson Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 82. Johnson &Johnson Cancer Supportive Care Medicine Product Portfolio Table 83. Johnson &Johnson Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 87. Novartis Cancer Supportive Care Medicine Product Portfolio Table 88. Novartis Recent Development Table 89. Merck Company Information Table 90. Merck Business Overview Table 91. Merck Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 92. Merck Cancer Supportive Care Medicine Product Portfolio Table 93. Merck Recent Development Table 94. GlaxoSmithKline Company Information Table 95. GlaxoSmithKline Business Overview Table 96. GlaxoSmithKline Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 97. GlaxoSmithKline Cancer Supportive Care Medicine Product Portfolio Table 98. GlaxoSmithKline Recent Development Table 99. Amgen Company Information Table 100. Amgen Business Overview Table 101. Amgen Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 102. Amgen Cancer Supportive Care Medicine Product Portfolio Table 103. Amgen Recent Development Table 104. TESARO Company Information Table 105. TESARO Business Overview Table 106. TESARO Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 107. TESARO Cancer Supportive Care Medicine Product Portfolio Table 108. TESARO Recent Development Table 109. Kyowa Hakko Kirin Company Information Table 110. Kyowa Hakko Kirin Business Overview Table 111. Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 112. Kyowa Hakko Kirin Cancer Supportive Care Medicine Product Portfolio Table 113. Kyowa Hakko Kirin Recent Development Table 114. Heron Therapeutics Company Information Table 115. Heron Therapeutics Business Overview Table 116. Heron Therapeutics Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 117. Heron Therapeutics Cancer Supportive Care Medicine Product Portfolio Table 118. Heron Therapeutics Recent Development Table 119. Helsinn Healthcare Company Information Table 120. Helsinn Healthcare Business Overview Table 121. Helsinn Healthcare Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 122. Helsinn Healthcare Cancer Supportive Care Medicine Product Portfolio Table 123. Helsinn Healthcare Recent Development Table 124. F. Hoffmann-La Roche Company Information Table 125. F. Hoffmann-La Roche Business Overview Table 126. F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 127. F. Hoffmann-La Roche Cancer Supportive Care Medicine Product Portfolio Table 128. F. Hoffmann-La Roche Recent Development Table 129. North America Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 130. North America Cancer Supportive Care Medicine Sales by Country (2021-2026) & (k tons) Table 131. North America Cancer Supportive Care Medicine Sales Market Share by Country (2021-2026) Table 132. North America Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 133. North America Cancer Supportive Care Medicine Sales Market Share Forecast by Country (2027-2032) Table 134. North America Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Cancer Supportive Care Medicine Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Cancer Supportive Care Medicine Market Share by Country (2021-2026) Table 137. North America Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Cancer Supportive Care Medicine Market Share Forecast by Country (2027-2032) Table 139. Europe Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 140. Europe Cancer Supportive Care Medicine Sales by Country (2021-2026) & (k tons) Table 141. Europe Cancer Supportive Care Medicine Sales Market Share by Country (2021-2026) Table 142. Europe Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 143. Europe Cancer Supportive Care Medicine Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Cancer Supportive Care Medicine Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Cancer Supportive Care Medicine Market Share by Country (2021-2026) Table 147. Europe Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Cancer Supportive Care Medicine Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Cancer Supportive Care Medicine Sales by Country (2021-2026) & (k tons) Table 151. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 153. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Cancer Supportive Care Medicine Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Cancer Supportive Care Medicine Market Share by Country (2021-2026) Table 157. Asia-Pacific Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Cancer Supportive Care Medicine Market Share Forecast by Country (2027-2032) Table 159. Latin America Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 160. Latin America Cancer Supportive Care Medicine Sales by Country (2021-2026) & (k tons) Table 161. Latin America Cancer Supportive Care Medicine Sales Market Share by Country (2021-2026) Table 162. Latin America Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 163. Latin America Cancer Supportive Care Medicine Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Cancer Supportive Care Medicine Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Cancer Supportive Care Medicine Market Share by Country (2021-2026) Table 167. Latin America Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Cancer Supportive Care Medicine Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Cancer Supportive Care Medicine Sales by Country (2021-2026) & (k tons) Table 171. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032) & (k tons) Table 173. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Cancer Supportive Care Medicine Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Cancer Supportive Care Medicine Market Share by Country (2021-2026) Table 177. Middle East and Africa Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Cancer Supportive Care Medicine Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Cancer Supportive Care Medicine Distributors List Table 182. Cancer Supportive Care Medicine Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Cancer Supportive Care Medicine Image Figure 2. Global Cancer Supportive Care Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Supportive Care Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Supportive Care Medicine Sales (2021-2032) & (k tons) Figure 5. Antiemetic Drugs Image Figure 6. Global Antiemetic Drugs Sales YoY Growth (2021-2032) & (k tons) Figure 7. Analgesics Image Figure 8. Global Analgesics Sales YoY Growth (2021-2032) & (k tons) Figure 9. Granulocyte-Stimulating Agents Image Figure 10. Global Granulocyte-Stimulating Agents Sales YoY Growth (2021-2032) & (k tons) Figure 11. Erythropoietin-Stimulating Agents Image Figure 12. Global Erythropoietin-Stimulating Agents Sales YoY Growth (2021-2032) & (k tons) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 15. Global Cancer Supportive Care Medicine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Cancer Supportive Care Medicine Market Share by Type 2025 VS 2032 Figure 17. North America Cancer Supportive Care Medicine Sales Market Share in Volume by Type in 2025 Figure 18. North America Cancer Supportive Care Medicine Sales Market Share in Value by Type in 2025 Figure 19. Europe Cancer Supportive Care Medicine Sales Market Share in Volume by Type in 2025 Figure 20. Europe Cancer Supportive Care Medicine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share in Value by Type in 2025 Figure 23. Latin America Cancer Supportive Care Medicine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Cancer Supportive Care Medicine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Cancer Supportive Care Medicine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Chemotherapy-Induced Anemia Image Figure 30. Global Chemotherapy-Induced Anemia Sales YoY Growth (2021-2032) & (k tons) Figure 31. Bone Metastasis Image Figure 32. Global Bone Metastasis Sales YoY Growth (2021-2032) & (k tons) Figure 33. Cancer Pain Image Figure 34. Global Cancer Pain Sales YoY Growth (2021-2032) & (k tons) Figure 35. Other Image Figure 36. Global Other Sales YoY Growth (2021-2032) & (k tons) Figure 37. Global Cancer Supportive Care Medicine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Cancer Supportive Care Medicine Market Share by Application 2025 VS 2032 Figure 39. North America Cancer Supportive Care Medicine Sales Market Share in Volume by Application in 2025 Figure 40. North America Cancer Supportive Care Medicine Sales Market Share in Value by Application in 2025 Figure 41. Europe Cancer Supportive Care Medicine Sales Market Share in Volume by Application in 2025 Figure 42. Europe Cancer Supportive Care Medicine Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Cancer Supportive Care Medicine Sales Market Share in Value by Application in 2025 Figure 45. Latin America Cancer Supportive Care Medicine Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Cancer Supportive Care Medicine Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Cancer Supportive Care Medicine Sales Market Share in Value by Application in 2025 Figure 49. North America Cancer Supportive Care Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. North America Cancer Supportive Care Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Cancer Supportive Care Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Cancer Supportive Care Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cancer Supportive Care Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Europe Cancer Supportive Care Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Cancer Supportive Care Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Cancer Supportive Care Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Cancer Supportive Care Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Asia-Pacific Cancer Supportive Care Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Cancer Supportive Care Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Cancer Supportive Care Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Cancer Supportive Care Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 62. Latin America Cancer Supportive Care Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Cancer Supportive Care Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Cancer Supportive Care Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Cancer Supportive Care Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 66. Middle East and Africa Cancer Supportive Care Medicine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Cancer Supportive Care Medicine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Cancer Supportive Care Medicine Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Cancer Supportive Care Medicine Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Cancer Supportive Care Medicine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Antiemetic Drugs
  • Analgesics
  • Granulocyte-Stimulating Agents
  • Erythropoietin-Stimulating Agents
  • Others
Applications
  • Chemotherapy-Induced Anemia
  • Bone Metastasis
  • Cancer Pain
  • Other
Companies covered
  • Teva Pharmaceutical Industries
  • Johnson &Johnson
  • Novartis
  • Merck
  • GlaxoSmithKline
  • Amgen
  • TESARO
  • Kyowa Hakko Kirin
  • Heron Therapeutics
  • Helsinn Healthcare
  • F. Hoffmann-La Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Supportive Care Medicine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cancer Supportive Care Medicine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cancer Supportive Care Medicine Market by Type
  6. 1.3.1 Antiemetic Drugs
  7. 1.3.2 Analgesics
  8. 1.3.3 Granulocyte-Stimulating Agents
  9. 1.3.4 Erythropoietin-Stimulating Agents
  10. 1.3.5 Others
  11. 1.4 Global Cancer Supportive Care Medicine Market Size by Type
  12. 1.4.1 Global Cancer Supportive Care Medicine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Cancer Supportive Care Medicine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Cancer Supportive Care Medicine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Cancer Supportive Care Medicine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Cancer Supportive Care Medicine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Cancer Supportive Care Medicine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Cancer Supportive Care Medicine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Cancer Supportive Care Medicine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cancer Supportive Care Medicine Industry Trends
  2. 2.2 Cancer Supportive Care Medicine Industry Drivers
  3. 2.3 Cancer Supportive Care Medicine Industry Opportunities and Challenges
  4. 2.4 Cancer Supportive Care Medicine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cancer Supportive Care Medicine Revenue (2021-2026)
  2. 3.2 Global Top Players by Cancer Supportive Care Medicine Sales (2021-2026)
  3. 3.3 Global Top Players by Cancer Supportive Care Medicine Price (2021-2026)
  4. 3.4 Global Cancer Supportive Care Medicine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Supportive Care Medicine Major Company Production Sites & Headquarters
  6. 3.6 Global Cancer Supportive Care Medicine Company, Product Type & Application
  7. 3.7 Global Cancer Supportive Care Medicine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Supportive Care Medicine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Supportive Care Medicine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Supportive Care Medicine Tier 1, Tier 2, and Tier 3
4 Cancer Supportive Care Medicine Regional Status and Outlook
  1. 4.1 Global Cancer Supportive Care Medicine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cancer Supportive Care Medicine Historic Market Size by Region
  3. 4.2.1 Global Cancer Supportive Care Medicine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cancer Supportive Care Medicine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cancer Supportive Care Medicine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cancer Supportive Care Medicine Forecasted Market Size by Region
  7. 4.3.1 Global Cancer Supportive Care Medicine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cancer Supportive Care Medicine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cancer Supportive Care Medicine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cancer Supportive Care Medicine by Application
  1. 5.1 Cancer Supportive Care Medicine Market by Application
  2. 5.1.1 Chemotherapy-Induced Anemia
  3. 5.1.2 Bone Metastasis
  4. 5.1.3 Cancer Pain
  5. 5.1.4 Other
  6. 5.2 Global Cancer Supportive Care Medicine Market Size by Application
  7. 5.2.1 Global Cancer Supportive Care Medicine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cancer Supportive Care Medicine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cancer Supportive Care Medicine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cancer Supportive Care Medicine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cancer Supportive Care Medicine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cancer Supportive Care Medicine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cancer Supportive Care Medicine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cancer Supportive Care Medicine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Cancer Supportive Care Medicine Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Johnson &Johnson
  8. 6.2.1 Johnson &Johnson Company Information
  9. 6.2.2 Johnson &Johnson Business Overview
  10. 6.2.3 Johnson &Johnson Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson &Johnson Cancer Supportive Care Medicine Product Portfolio
  12. 6.2.5 Johnson &Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Cancer Supportive Care Medicine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Merck
  20. 6.4.1 Merck Company Information
  21. 6.4.2 Merck Business Overview
  22. 6.4.3 Merck Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck Cancer Supportive Care Medicine Product Portfolio
  24. 6.4.5 Merck Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Cancer Supportive Care Medicine Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Amgen
  32. 6.6.1 Amgen Company Information
  33. 6.6.2 Amgen Business Overview
  34. 6.6.3 Amgen Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Amgen Cancer Supportive Care Medicine Product Portfolio
  36. 6.6.5 Amgen Recent Developments
  37. 6.7 TESARO
  38. 6.7.1 TESARO Company Information
  39. 6.7.2 TESARO Business Overview
  40. 6.7.3 TESARO Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 TESARO Cancer Supportive Care Medicine Product Portfolio
  42. 6.7.5 TESARO Recent Developments
  43. 6.8 Kyowa Hakko Kirin
  44. 6.8.1 Kyowa Hakko Kirin Company Information
  45. 6.8.2 Kyowa Hakko Kirin Business Overview
  46. 6.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kyowa Hakko Kirin Cancer Supportive Care Medicine Product Portfolio
  48. 6.8.5 Kyowa Hakko Kirin Recent Developments
  49. 6.9 Heron Therapeutics
  50. 6.9.1 Heron Therapeutics Company Information
  51. 6.9.2 Heron Therapeutics Business Overview
  52. 6.9.3 Heron Therapeutics Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Heron Therapeutics Cancer Supportive Care Medicine Product Portfolio
  54. 6.9.5 Heron Therapeutics Recent Developments
  55. 6.10 Helsinn Healthcare
  56. 6.10.1 Helsinn Healthcare Company Information
  57. 6.10.2 Helsinn Healthcare Business Overview
  58. 6.10.3 Helsinn Healthcare Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Helsinn Healthcare Cancer Supportive Care Medicine Product Portfolio
  60. 6.10.5 Helsinn Healthcare Recent Developments
  61. 6.11 F. Hoffmann-La Roche
  62. 6.11.1 F. Hoffmann-La Roche Company Information
  63. 6.11.2 F. Hoffmann-La Roche Business Overview
  64. 6.11.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 F. Hoffmann-La Roche Cancer Supportive Care Medicine Product Portfolio
  66. 6.11.5 F. Hoffmann-La Roche Recent Developments
7 North America by Country
  1. 7.1 North America Cancer Supportive Care Medicine Sales by Country
  2. 7.1.1 North America Cancer Supportive Care Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cancer Supportive Care Medicine Sales by Country (2021-2026)
  4. 7.1.3 North America Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cancer Supportive Care Medicine Market Size by Country
  6. 7.2.1 North America Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cancer Supportive Care Medicine Market Size by Country (2021-2026)
  8. 7.2.3 North America Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cancer Supportive Care Medicine Sales by Country
  2. 8.1.1 Europe Cancer Supportive Care Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cancer Supportive Care Medicine Sales by Country (2021-2026)
  4. 8.1.3 Europe Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cancer Supportive Care Medicine Market Size by Country
  6. 8.2.1 Europe Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cancer Supportive Care Medicine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cancer Supportive Care Medicine Sales by Country
  2. 9.1.1 Asia-Pacific Cancer Supportive Care Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cancer Supportive Care Medicine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cancer Supportive Care Medicine Market Size by Country
  6. 9.2.1 Asia-Pacific Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cancer Supportive Care Medicine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cancer Supportive Care Medicine Sales by Country
  2. 10.1.1 South America Cancer Supportive Care Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cancer Supportive Care Medicine Sales by Country (2021-2026)
  4. 10.1.3 South America Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cancer Supportive Care Medicine Market Size by Country
  6. 10.2.1 South America Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cancer Supportive Care Medicine Market Size by Country (2021-2026)
  8. 10.2.3 South America Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cancer Supportive Care Medicine Sales by Country
  2. 11.1.1 Middle East and Africa Cancer Supportive Care Medicine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cancer Supportive Care Medicine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cancer Supportive Care Medicine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cancer Supportive Care Medicine Market Size by Country
  6. 11.2.1 Middle East and Africa Cancer Supportive Care Medicine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cancer Supportive Care Medicine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cancer Supportive Care Medicine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cancer Supportive Care Medicine Value Chain Analysis
  2. 12.1.1 Cancer Supportive Care Medicine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cancer Supportive Care Medicine Production Mode & Process
  7. 12.2 Cancer Supportive Care Medicine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cancer Supportive Care Medicine Distributors
  10. 12.2.3 Cancer Supportive Care Medicine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst